Blood-Based Biomarkers Could Help Predict Schizophrenia Risk in Cannabis Users
May 7, 2025
Untargeted lipidomics reveals striking metabolic differences between patients with schizophrenia, cannabis use disorder, and dual-diagnosis
1 min read
False
May 7, 2025
Untargeted lipidomics reveals striking metabolic differences between patients with schizophrenia, cannabis use disorder, and dual-diagnosis
1 min read
May 7, 2025
A multi-omics study distinguishes two subtypes of chronic liver disease that may progress to liver cancer via distinct molecular pathways
2 min read
April 9, 2025
Nanotube sensor can continuously detect hundreds of metabolites in vivo with enzymatic precision
3 min read
April 7, 2025
Stanford study uses mass spectrometry and transcriptomics to reveal sugar’s non-metabolic role
3 min read
February 5, 2025
Peptide drug development has made great progress in recent years – in large part thanks to new purification and separation technologies; however, method development remains an expensive challenge. We spoke with KNAUER’s Ulrike Krop to learn more about the company’s systematic and cost-saving approach to scale-up.
3 min read
By Jeremy Nicholson
January 20, 2025
Jeremy Nicholson explores the potential of metabolic phenotyping in personalized medicine
4 min read
By James Strachan
December 27, 2024
What were The Analytical Scientist’s most popular online articles in 2024? Here are our top 10 most read…
3 min read
By James Strachan
December 24, 2024
Looking back on 12 months of mass spectrometry-based omics breakthroughs
6 min read
December 19, 2024
What are the most exciting developments and emerging trends in analytical science today? We asked the 2024 Power List
4 min read
December 11, 2024
Meet the products – and the experts – defining analytical innovation in 2024
10 min read
False
False
False